Common variants on Xq28 conferring risk of schizophrenia in Han Chinese

Schizophrenia Bulletin

Volumn 40, Issue 4, 2014, Pages 777-786

  Wong, Emily H M ^a   So, Hon Cheong ^a   Li, Miaoxin ^a   Wang, Quang ^b   Butler, Amy W ^a,c   Paul, Basil ^a   Wu, Hei Man ^a   Hui, Tomy C K ^a   Choi, Siu Chung ^a   So, Man Ting ^a   Garcia Barcelo, Maria Mercè ^a   McAlonan, Grainne M ^c   Chen, Eric Y H ^a   Cheung, Eric F C ^d   Chan, Raymond C K ^e   Purcell, Shaun M ^f   Cherny, Stacey S ^a,g   Chen, Ronald R L ^a   Li, Tao ^b   Sham, Pak Chung ^a,g  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN UNIVERSITY   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CASTLE PEAK HOSPITAL   (Hong Kong)

^e INSTITUTE OF PSYCHOLOGY   (China)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ARHGAP4; genome wide association study; Han Chinese; MECP2; RENBP; schizophrenia

Indexed keywords

METHYL CPG BINDING PROTEIN 2; ARHGAP4 PROTEIN, HUMAN; CARRIER PROTEIN; EPIMERASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MECP2 PROTEIN, HUMAN; RENBP PROTEIN, HUMAN;

ALLELE; ARHGAP4 GENE; ARTICLE; CHROMOSOME XQ; CHROMOSOME XQ28; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MULTIFACTORIAL INHERITANCE; MULTIGENE FAMILY; PRIORITY JOURNAL; RENBP GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; STATISTICAL MODEL; X CHROMOSOME;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARBOHYDRATE EPIMERASES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, X; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GTPASE-ACTIVATING PROTEINS; HUMANS; LOGISTIC MODELS; MALE; METHYL-CPG-BINDING PROTEIN 2; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84899895669     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt104     Document Type: Article

References (52)

1. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and feld synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40:827-834.
2. Kirov G, Zaharieva I, Georgieva L, et al. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry. 2009;14:796-803.
3. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
4. Shi Y, Li Z, Xu Q, et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet. 2011;43:1224-1227.
5. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study identifes fve new schizophrenia loci. Nat Genet. 2011;43:969-976.
6. Yue WH, Wang HF, Sun LD, et al. Genome-wide association study identifes a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet. 2011;43:1228-1231.
7. Xiao SM, Kung AW, Gao Y, et al. Post-genome wide association studies and functional analyses identify association of MPP7 gene variants with site-specifc bone mineral density. Hum Mol Genet. 2012;21:1648-1657.
8. Guo Y, Tomlinson B, Chu T, et al. A genome-wide linkage and association scan reveals novel loci for hypertension and blood pressure traits. PLoS One. 2012;7:e31489.
9. Chan KY, Wong CM, Kwan JS, et al. Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection. PLoS One. 2011;6:e28798.
10. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratifcation in genome-wide association studies. Nat Genet. 2006;38:904-909.
11. Howie BN, Donnelly P, Marchini J. A fexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529.
12. Clayton DG. Sex chromosomes and genetic association studies. Genome Med. 2009;1:110.
13. Clayton D. Testing for association on the X chromosome. Biostatistics. 2008;9:593-600.
14. Li MX, Gui HS, Kwan JS, Sham PC. GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet. 2011;88:283-293.
15. Psychiatric GWAS Consortium Bipolar Disorder Worki ng Group. Large-scale genome-wide association analysis of bipolar disorder identifes a new susceptibility locus near ODZ4. Nat Genet. 2011;43:977-983.
16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
17. Ma L, Tang J, Wang D, et al. Evaluating risk loci for schizophrenia distilled from genome-wide association studies in Han Chinese from central China. Mol Psychiatry. 2011;18:638-639.
18. Ikeda M, Aleksic B, Yamada K, et al. Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population. Mol Psychiatry. 2013;18:636-638.
19. Sullivan PF, Kendler KS, Neale MC Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187-1192.
20. McGuffn P, Owen MJ, Farmer AE. Genetic basis of schizophrenia. Lancet. 1995;346:678-682.
21. Lichtenstein P, Yip BH, Björk C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234-239.
22. Crescenti A, Gassó P, Mas S, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population. Psychiatry Res. 2009;165:175-180.
23. Kucukali CI, Aydin M, Ozkok E, et al. Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their frst-degree relatives. Psychiatr Genet. 2010;20:14-19.
24. Jenkins TA, Allen AM, Chai SY, MacGregor DP, Paxinos G, Mendelsohn FA. Interactions of angiotensin II with central dopamine. Adv Exp Med Biol. 1996;396:93-103.
25. Jenkins TA, Mendelsohn FA, Chai SY Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem. 1997;68:1304-1311.
26. Wright JW, Harding JW The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog Neurobiol. 2004;72:263-293.
27. LaSalle JM, Goldstine J, Balmer D, Greco CM. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet. 2001;10:1729-1740.
28. Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320:1224-1229.
29. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-188.
30. Williamson SL, Christodoulou J. Rett syndrome: new clinical and molecular insights. Eur J Hum Genet. 2006;14: 896-903.
31. Shibayama A, Cook EH Jr, Feng J, et al. MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet. 2004;128B:50-53.
32. Gécz J, Shoubridge C, Corbett M. The genetic landscape of intellectual disability arising from chromosome X. Trends Genet. 2009;25:308-316.
33. Geerdink N, Rotteveel JJ, Lammens M, et al. MECP2 mutation in a boy with severe neonatal encephalopathy: clinical, neuropathological and molecular fndings. Neuropediatrics. 2002;33:33-36.
34. Cohen D, Lazar G, Couvert P, et al. MECP2 mutation in a boy with language disorder and schizophrenia. Am J Psychiatry. 2002;159:148-149.
35. Joyner AH, J CR, Bloss CS, et al. A common MECP2 haplo-type associates with reduced cortical surface area in humans in two independent populations. Proc Natl Acad Sci U S A. 2009;106:15483-15488.
36. Colibazzi T, Wexler BE, Bansal R, et al. Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia. PLoS One. 2013;8:e55783.
37. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J et al. Dysfunction in GABA signalling mediates autismlike stereotypies and Rett syndrome phenotypes. Nature 2010;468:263-269.
38. Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, et al. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) 2005;180:191-205.
39. Blum BP, Mann JJ. The GABAergic system in schizophrenia. The Int J Neuropsychopharmacol/offcial scientifc journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2002;5:159-179.
40. Costa E, Davis JM, Dong E, Grayson DR, Guidotti A, Tremolizzo L, et al. A GABAergic cortical defcit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 2004;16:1-23.
41. Nakazawa K, Zsiros V, Jiang Z, Nakao K, Kolata S, Zhang S, et al. GABAergic interneuron origin of schizophrenia pathophysiology [published online ahead of print 2011]. Neuropharmacology.
42. Szulwach KE, Li X, Smrt RD, et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol. 2010;189:127-141.
43. Vogt DL, Gray CD, Young WS 3rd, Orellana SA, Malouf AT. ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth. Mol Cell Neurosci. 2007;36:332-342.
44. Sasayama D, Hori H, Teraishi T, et al. Possible association between interleukin-1β gene and schizophrenia in a Japanese population. Behav Brain Funct. 2011;7:35.
45. Söderlund J, Schröder J, Nordin C, et al. Activation of brain interleukin-1beta in schizophrenia. Mol Psychiatry. 2009;14:1069-1071.
46. Marx CE, Jarskog LF, Lauder JM, Lieberman JA, Gilmore JH. Cytokine effects on cortical neuron MAP-2 immuno-reactivity: implications for schizophrenia. Biol Psychiatry. 2001;50:743-749.
47. Byun MS, Kim JS, Jung WH, et al. Regional cortical thinning in subjects with high genetic loading for schizophrenia. Schizophr Res. 2012;141:197-203.
48. Shi Y, Li Z, Xu Q, et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet. 2011;43:1224-1227.
49. Yue WH, Wang HF, Sun LD, et al. Genome-wide association study identifes a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet. 2011;43:1228-1231.
50. Le-Niculescu H, Patel SD, Bhat M, et al. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identifcation of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet. 2009;150B:155-181.
51. Terracciano A, Tanaka T, Sutin AR, et al. Genome-wide association scan of trait depression. Biol Psychiatry. 2010;68:811-817.
52. Soria V, Martínez-Amorós E, Escaramís G, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology. 2010;35:1279-1289.